Title for MeetingAbstracts
Alphabetical listing of titles
Weathering the Storm: Safety Net Providers in New Health Care Markets.
Weathering the storm: women's experiences of living with HIV / AIDS.
WEATOC (We're Educators-A touch of class): A model HIV prevention and education by and for youth program.
Weaving a new life for children affected by HIV/AIDS in Battambang, Cambodia.
Weaving Networks.
Weaving stories against prejudice: A Mexican experience.
Weaving the basket of self-care: building a community of wellness.
Web Based Client Information Systems in Community Based Mental Health Care: Are Staff Ready, Willing, and Able?
Web site aiming clients of female sex workers.
Web-assisted improvement of the appropriateness of care: EPAGE.
Web-based interactive tool for European education training and accreditation in hematology.
Week 2 - Nevirapine (NVP) plasma levels are associated with NVP-related toxicity.
Weekly dapsone and dapsone/pyrimethamine for PCP prophylaxis.
Weekly Dosing with Epoetin Alpha in HIV-Infected Patients with Anemia: Interim Data.
Weekly low dose of G-CSF treatment in patients with AIDS and iatrogenic neutropenia.
Weekly Rifapentine and INH Versus Twice Weekly Rifampin/INH in the Continuation Phase of Therapy for HIV Negative Patients with Pulmonary Tuberculosis (TB); Final Results from USPHS Study 22.
Weekly treatment for prophylaxis of candida vaginitis.
Weeping widows: funeral rites and the transmission of HIV/AIDS in Siaya district, Kenya.
Weighing consistency rates in EuroQol health state valuations.
Weighing the evidence: linking prevention with care.
Weight and Body Shape Changes Associated with Antiretroviral Therapy in South India: Initial Prospective Analysis.
Weight and height growth velocity and short-term disease progression in HIV-infected children.
Weight as a predictor variable for advancement of HIV infection in women.
Weight gain and appetite stimulation with medroxyprogesterone acetate (MPA) in AIDS patients with cachexia and anorexia.
Weight gain in patients with AIDS-related complex and diarrhea or candidiasis treated with IMREG-1 or placebo.
Weight gain with the use of megace in patients with AIDS in Mexico.
Weight loss > 10% and body mass index as predictors of survival after AIDS diagnosis in the Aquitaine cohort, France, 1985-1997.
Weight loss as a marker for disease progression in Thai HIV-infected patients.
Weight loss as a predictor of survival after AIDS among HIV-infected gay men enrolled in the MACS.
Weight Loss in HIV/HCV-Coinfected patients on HAART plus Interferon + Ribavirin.